Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data

Marscha S. Holleman, Carin A. Uyl-de Groot, Stephen Goodall, Naomi van der Linden

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
1 Downloads (Pure)
Original languageEnglish
Pages (from-to)322-331
JournalValue in health
Volume22
Issue number3
DOIs
Publication statusPublished - Mar 2019
Externally publishedYes

Cite this